'Everything looks expensive or horribly expensive': GMO reduces seven-year forecasts across all asset classes in Q4

EM value most bullish position

Tom Eckett
clock • 2 min read

Grantham Mayo Van Otterloo & Co (GMO), the global asset manager with $77bn AUM, has reduced its seven-year forecasts across asset classes following rising prices globally, with US large caps set to be the worst performers over the period while it backs emerging market value to come out on top.

According to the investment firm's Q4 Seven-year asset class real return forecasts, US large caps will fall 4.4% on an annual basis, compared to a forecast of -3.1% made in Q4 2016.  Meanwhile, emerging markets are set to return 2% per annum, half the team's estimates of 4.4% made in Q4 last year. However, despite the reduction in its forecasts for emerging market (EM) returns, Tommy Garvey, member of GMO's asset allocation team, said the huge discrepancy in price between EM growth and value stocks was the firm's biggest opportunity. Garvey said EM value had so far been left behind...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Funds